PATENT CLAIM ANALYSIS

Application Number: 16029219
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "635000"]

Abstract:
Methods and compositions using a combination of adenosine monophosphate protein kinase (AMPK) activators for treating pain such as post-surgical pain or development of chronic pain. The two or more AMPK activators work synergistically and may be administered in individually sub-efficacious doses. The AMPK activators may have different mechanisms of AMPK activation. The AMPK activators may be administered systemically and/or topically in, for example, as a gel, ointment, cream, lotion, suspension, liquid, or transdermal patch.

Claim (Index 20):
The method of  claim 19 , wherein the pain is neuropathy pain, acute pain, incision-induced hypersensitivity, incision-induced hyperalgesic priming, or incision-induced development of chronic pain.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 95.0
- Lexical Diversity: 1.62963
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14956042', '14318245', '15595911', '15817057', '14927255']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7610242886154113
- 35 USC 102 Novelty (BERT): 0.6237994469928314
- Combined Prediction Score: 0.7473018044531533
- Mean Citation Score: 456.986266
- Max Citation Score: 831.9531
- Similarity Product: 485.8490987808824

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test